These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19591850)

  • 21. Role of orexin/hypocretin in conditioned sucrose-seeking in female rats.
    Cason AM; Aston-Jones G
    Neuropharmacology; 2014 Nov; 86():97-102. PubMed ID: 25036612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin₁ receptors.
    Jupp B; Krstew E; Dezsi G; Lawrence AJ
    Br J Pharmacol; 2011 Feb; 162(4):880-9. PubMed ID: 20973776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol--preferring Sprague--Dawley rats.
    Moorman DE; Aston-Jones G
    Alcohol; 2009 Aug; 43(5):379-86. PubMed ID: 19671464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermal nociception is decreased by hypocretin-1 and an adenosine A1 receptor agonist microinjected into the pontine reticular formation of Sprague Dawley rat.
    Watson SL; Watson CJ; Baghdoyan HA; Lydic R
    J Pain; 2010 Jun; 11(6):535-44. PubMed ID: 20015707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orexin-1 receptor signaling increases motivation for cocaine-associated cues.
    Bentzley BS; Aston-Jones G
    Eur J Neurosci; 2015 May; 41(9):1149-56. PubMed ID: 25754681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats.
    Zhou Y; Cui CL; Schlussman SD; Choi JC; Ho A; Han JS; Kreek MJ
    Neuroscience; 2008 Jun; 153(4):1225-34. PubMed ID: 18436386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid.
    Chou YH; Hor CC; Lee MT; Lee HJ; Guerrini R; Calo G; Chiou LC
    Addict Biol; 2021 May; 26(3):e12971. PubMed ID: 33078457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.
    Plaza-Zabala A; Martín-García E; de Lecea L; Maldonado R; Berrendero F
    J Neurosci; 2010 Feb; 30(6):2300-10. PubMed ID: 20147556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orexin/hypocretin receptor 1 signaling mediates Pavlovian cue-food conditioning and extinction.
    Keefer SE; Cole S; Petrovich GD
    Physiol Behav; 2016 Aug; 162():27-36. PubMed ID: 26945612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hypocretin/orexin system mediates the extinction of fear memories.
    Flores Á; Valls-Comamala V; Costa G; Saravia R; Maldonado R; Berrendero F
    Neuropsychopharmacology; 2014 Nov; 39(12):2732-41. PubMed ID: 24930888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypocretin/orexin deficiency decreases cocaine abuse liability.
    Steiner N; Rossetti C; Sakurai T; Yanagisawa M; de Lecea L; Magistretti PJ; Halfon O; Boutrel B
    Neuropharmacology; 2018 May; 133():395-403. PubMed ID: 29454841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system.
    Cannella N; Economidou D; Kallupi M; Stopponi S; Heilig M; Massi M; Ciccocioppo R
    Neuropsychopharmacology; 2009 Aug; 34(9):2125-34. PubMed ID: 19322167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro.
    Yu L; Zhang XY; Zhang J; Zhu JN; Wang JJ
    Cerebellum; 2010 Mar; 9(1):88-95. PubMed ID: 19921532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats.
    James MH; Bowrey HE; Stopper CM; Aston-Jones G
    Eur J Neurosci; 2019 Aug; 50(3):2602-2612. PubMed ID: 30240516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
    Rasmussen K; Hsu MA; Yang Y
    Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity.
    Gompf HS; Aston-Jones G
    Brain Res; 2008 Aug; 1224():43-52. PubMed ID: 18614159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system.
    Fragale JE; James MH; Aston-Jones G
    Addict Biol; 2021 May; 26(3):e12946. PubMed ID: 32798290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orexin-A/Hypocretin-1 Mediates Cocaine-Seeking Behavior in the Posterior Paraventricular Nucleus of the Thalamus via Orexin/Hypocretin Receptor-2.
    Matzeu A; Kerr TM; Weiss F; Martin-Fardon R
    J Pharmacol Exp Ther; 2016 Nov; 359(2):273-279. PubMed ID: 27540003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation.
    Silveyra P; Lux-Lantos V; Libertun C
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E977-85. PubMed ID: 17638707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats.
    James MH; Stopper CM; Zimmer BA; Koll NE; Bowrey HE; Aston-Jones G
    Biol Psychiatry; 2019 Jun; 85(11):925-935. PubMed ID: 30219208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.